ชื่อผู้ได้มา/จำหน่าย :?NEW YORK LIFE INTERNATIONAL, INC. | ประเภทหลักทรัพย์ : หุ้น | วันที่มีหน้าที่ : 03/10/2545
ชื่อผู้ได้มา/จำหน่าย :?NEW YORK LIFE INTERNATIONAL, LLC. | ประเภทหลักทรัพย์ : หุ้น | วันที่มีหน้าที่ : 03/10/2545
ชื่อผู้ได้มา/จำหน่าย :?THE MANUFACTURERS LIFE INSURANCE COMPANY | ประเภทหลักทรัพย์ : หุ้น | วันที่มีหน้าที่ : 30/11/2547
management has been one of the SEC's key policies, aiming to bring about financial stability and quality of life for the Thais. ?Being Money-Wise for the Bright Future? project will provide a guideline for
management has been one of the SEC?s key policies, aiming to bring about financial stability and quality of life for the Thais. ?Being Money-Wise for the Bright Future? project will provide a guideline for
granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change
Consolidated financial statements Change Increase/(Decrease) For Three Months Period Ended 30 September 2017 2018 THB mm % THB mm % THB mm % Sale Revenue Revenue from selling product under Company’s trademark 1
July 2018 with a gain from business combination of Baht 276 million which should be amortised by Baht 12 million per annum along the PPA life. BGRIM started to consolidate BGYSP’s financial statement in
) operating results based on its reviewed consolidated financial statements ended 31 March 2019 as follows. Highlights on Q1-2019 Operating results Unit : Million Baht Q1-19 Q1-18 Q4-18 % Change Amount % Amount
results for the six-month period of 2019, change of rate more than 20 percent Dear Director and Manager The Stock Exchange of Thailand According to the resolution of the Board of Directors of DOD Biotech